Currently submitted to: JMIR Research Protocols
Date Submitted: Mar 19, 2026
Open Peer Review Period: Mar 19, 2026 - May 14, 2026
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effects of Intermittent Fasting Regimens on Inflammatory Markers in Adult Patients with Prediabetes, T2DM or Metabolic Syndrome: Protocol for a Systematic Review and Meta- analysis.
ABSTRACT
Background:
Type 2 diabetes mellitus (T2DM) has become a major health burden worldwide, therefore strategies to manage it in early stages are continuously being investigated. Excessive calorie consumption and sedentary lifestyles which are accompanied by the development of a low-grade inflammatory state, are one of the key risk factors for the development of prediabetes, metabolic syndrome and the subsequent T2DM. Lifestyle modifications like intermittent fasting (IF) have become an important aspect in the management of T2DM. Current evidence on the effects of IF on low-grade inflammation in individuals with either prediabetes, metabolic syndrome or T2DM is inconsistent. This systematic review protocol outlines the planned synthesis and evaluation of existing literature investigating the effectiveness of IF on inflammatory markers of adult patients with prediabetes T2DM or metabolic syndrome.
Objective:
The main objective of this review is to analyse data of previously published studies investigating effects of different IF regimens by assessing inflammatory markers of patients with prediabetes, metabolic syndrome or T2DM.
Methods:
This protocol is prepared in accordance with the Preferred Reporting Items for Systematic Review and Meta-analysis Protocol (PRISMA-P) 2020. Databases including PubMed/Medline, PubMed Central, Scopus and Google Scholar will be systematically searched for published randomized controlled trials and longitudinal studies, including cohort, case-control, cross-sectional, observational, retrospective and prospective studies involving all types of intermittent fasting in adult humans with prediabetes or T2DM OR metabolic syndrome. Eligible participants will be adults (≥18 years) diagnosed with metabolic syndrome, prediabetes or T2DM using the American Diabetes Association (ADA) or the World Health Organisation (WHO) criteria. Systematic reviews, conference abstracts, editorials and meta-analyses will be excluded. Additionally, studies without a control group will be excluded unless they provide baseline vs. follow-up inflammatory data. The control group in randomized controlled trials will consist of subjects on their usual diet, continuous energy restriction or standard diabetic care. Active comparators like Mediterranean diet will be allowed if inflammatory markers are reported. Data on changes in inflammatory markers between the intervention and control group, as well as between baseline and post intervention will be extracted. The extracted data will be verified by a second reviewer and disagreements will be resolved by a third reviewer. The risk of bias of the included randomized controlled trials will be assessed using the Cochrane Risk of Bias 2 (RoB 2), while for longitudinal studies the National Institutes of Health (NIH) quality assessment tool for Before-After (Pre-post) studies with no control group will be used. Review Manager (RevMan) will be used to perform a meta-analysis where sufficient data are available and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to assess the quality of evidence.
Results:
This review will only use publicly available published data. The findings of this review will provide a comprehensive synthesis of the current evidence regarding the effects of intermittent fasting regimens on inflammatory markers of adult patients with either T2DM, prediabetes or metabolic syndrome.
Conclusions:
The findings will highlight the current knowledge gaps and inform future clinical research, which may help to guide early intervention strategies to manage prediabetes or metabolic syndrome and to prevent the onset of T2DM. Clinical Trial: International Prospective Register of Systematic Reviews (PROSPERO) CRD420251133867, https://www.crd.york.ac.uk/PROSPERO/view/CRD420251133867
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.